Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.52 |
| ▸ | CCR1 | P32246 | 1/20 | 0.52 |
| ▸ | CCR5 | P51681 | 1/20 | 0.52 |
| ▸ | CCR8 | P51685 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 6/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | NOS3 | P29474 | 1/20 | 0.48 |
| ▸ | NOS1 | P29475 | 1/20 | 0.48 |
| ▸ | NOS2 | P35228 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | PLAU | P00749 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | PRKCI | P41743 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29508711 | 1.00 | UHRF1 (0.52) | UHRF1CCR1CCR5CCR8LMNA | |
| SCHEMBL7002997 | 0.85 | UHRF1 (0.53) | UHRF1CCR1CCR5CCR8LMNA | |
| SCHEMBL16094048 | 0.84 | UHRF1 (0.50) | UHRF1CCR1CCR5CCR8LMNA | |
| SCHEMBL31032211 | 0.84 | UHRF1 (0.50) | UHRF1CCR1CCR5CCR8LMNA | |
| SCHEMBL8154445 | 0.82 | KDM4E (0.50) | UHRF1CCR1CCR5CCR8LMNA | |
| SCHEMBL14297355 | 0.82 | UHRF1 (0.48) | UHRF1CCR1CCR5CCR8LMNA | |
| SCHEMBL129055 | 0.82 | UHRF1 (0.48) | UHRF1CCR1CCR5CCR8LMNA | |
| SCHEMBL29608524 | 0.82 | UHRF1 (0.48) | UHRF1CCR1CCR5CCR8LMNA | |
| SCHEMBL132321 | 0.79 | LOXL2 (0.52) | UHRF1CCR1CCR5CCR8KDM4E | |
| SCHEMBL30262293 | 0.79 | LOXL2 (0.52) | UHRF1CCR1CCR5CCR8KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 506 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8791279-B2 | Process for preparing taxoids from baccatin derivatives using lewis acid catalyst | YUNG SHIN PHARM. IND. CO., LTD. (TW) | 2014-07-29 | — | — | US | claimed |
| US-20120149925-A1 | PROCESS FOR PREPARING TAXOIDS FROM BACCATIN DERIVATIVES USING LEWIS ACID CATALYST | YUNG SHIN PHARM. IND. CO., LTD. (TW) | 2012-06-14 | — | — | US | claimed |
| EP-1172878-B1 | Non-aqueous electrolytic solution and secondary battery containing same | MITSUBISHI CHEM CORP (JP) | 2011-06-22 | — | — | EP | claimed |
| US-7595370-B2 | Reacting cyclosiloxane with unsaturated organosilylated carboxylate monomer or copolymer under presence of catalyst; antifouling paints, marine systems | PPG B.V. (NL) | 2009-09-29 | — | — | US | claimed |
| US-20060142516-A1 | Process for the preparation of polyorganosilylated carboxylate monomers or polymers thereof | SIGMA COATINGS B.V. (NL) | 2006-06-29 | — | — | US | claimed |
| EP-1539861-A1 | PROCESS FOR THE PREPARATION OF POLYORGANOSILYLATED CARBOXYLATE MONOMERS OR POLYMERS THEREOF | Sigmakalon Services B.V. (NL) | 2005-06-15 | — | — | EP | claimed |
| US-6767671-B2 | STABILITY; HEAT RESISTANCE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-07-27 | — | — | US | claimed |
| WO-2004007591-A1 | PROCESS FOR THE PREPARATION OF POLYORGANOSILYLATED CARBOXYLATE MONOMERS OR POLYMERS THEREOF | SIGMAKALON SERVICES B.V. (NL) | 2004-01-22 | — | — | WO | claimed |
| US-20020025477-A1 | Non-aqueous electrolytic solution and secondary battery containing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-02-28 | — | — | US | claimed |
| EP-1172878-A2 | Non-aqueous electrolytic solution and secondary battery containing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-01-16 | — | — | EP | claimed |
| EP-4608509-A1 | NEW INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-09-03 | — | — | EP | disclosed |
| US-20240239809-A1 | THERAPEUTIC AGENTS FOR ENHANCING EPITHELIAL AND/OR ENDOTHELIAL BARRIER FUNCTION | ARTUS THERAPEUTICS INC (US) | 2024-07-18 | — | — | US | disclosed |
| US-12037324-B2 | Biarylmethyl heterocycles | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-07-16 | — | — | US | disclosed |
| US-12037324-B2 | Biarylmethyl heterocycles | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-07-16 | — | — | US | disclosed |
| US-20240217963-A1 | RECEPTOR-INTERACTING PROTEIN 1 INHIBITORS, PREPARATIONS, AND USES THEREOF | Sironax Ltd. (KY) | 2024-07-04 | — | — | US | disclosed |
| EP-0264183-A1 | Derivatives of 5-methyl-10,11-dihydro-5H-dibenzo-(a,d) cyclohepten-5,10-imine | MERCK & CO. INC. (US) | 1988-04-20 | — | — | EP | disclosed |
| US-4725373-A | CORROSION RESISTANCE FOR METAL TOOLS AND EQUIPMENT USED IN OIL AND GAS WELLS | THE DOW CHEMICAL COMPANY (US) | 1988-02-16 | — | — | US | disclosed |
| US-4724003-A | Asphalt compositions containing anti-stripping additives prepared from hydrocarbyl substituted nitrogen-containing aromatic heterocyclic compounds, aldehydes or ketones and amines | THE DOW CHEMICAL COMPANY (US) | 1988-02-09 | — | — | US | disclosed |
| EP-0242289-A1 | Process for the preparation of oxazinobenzothiazine 6,6-dioxide derivatives | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 1987-10-21 | — | — | EP | disclosed |
| US-4676834-A | Novel compositions prepared from methyl substituted nitrogen-containing aromatic heterocyclic compounds and an aldehyde or ketone | THE DOW CHEMICAL COMPANY (US) | 1987-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149925-A1 | PROCESS FOR PREPARING TAXOIDS FROM BACCATIN DERIVATIVES USING LEWIS ACID CATALYST | TBCA, CEL, LTN1 | UHRF1 1747/4885CCR1 2128/4885CCR5 1298/4885 |
| US-20060142516-A1 | Process for the preparation of polyorganosilylated carboxylate monomers or polymers thereof | C1R, C9, PCBP1 | UHRF1 2459/4885CCR1 267/4885CCR5 298/4885 |
| US-20240239809-A1 | THERAPEUTIC AGENTS FOR ENHANCING EPITHELIAL AND/OR ENDOTHELIAL BARRIER FUNCTION | LIPG, FABP2, EPCAM | UHRF1 3641/4885CCR1 1037/4885CCR5 1004/4885 |
| US-12037324-B2 | Biarylmethyl heterocycles | ARRB1, ADRB2, ADRB1 | UHRF1 4381/4885CCR1 588/4885CCR5 153/4885 |
| US-20240217963-A1 | RECEPTOR-INTERACTING PROTEIN 1 INHIBITORS, PREPARATIONS, AND USES THEREOF | RIPK1, RIPK2, RIPK4 | UHRF1 864/4885CCR1 1383/4885CCR5 1961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.